Mohammad A. Hammoude, MD

Endocrinology in Sterling Heights, MI

44700 Delco Blvd, Suite A, Sterling Heights, MI 48313 · Endocrine Shores PC
NPI 1265559488 Accepts Medicare assignment 29 years since graduation Public record — not managed by the clinician

About Dr. Mohammad Hammoude

Dr. Mohammad Hammoude is a physician specializing in endocrinology practicing in Sterling Heights, MI. Records list 2 practice addresses. Affiliated with Corewell Health Beaumont Grosse Pointe Hospital, Corewell Health Beaumont Troy Hospital, Corewell Health William Beaumont University Hospit and 2 more. Treated 790 Medicare patients in 2024.

SpecialtyEndocrinologyOther endocrinology doctors in Sterling Heights
Also practicesInternal Medicine
CredentialsMD
GenderMale
NPI number1265559488National Provider Identifier (CMS NPPES), issued March 2007
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Where Dr. Mohammad Hammoude practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Mohammad Hammoude's specialties and state licenses

Specialty (NPPES)License
Internal Medicine PrimaryMI 4301083021
HospitalistMI 4301083021

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Mohammad Hammoude

  • Corewell Health Beaumont Grosse Pointe HospitalHospital · Grosse Pointe, MI
  • Corewell Health Beaumont Troy HospitalHospital · Troy, MI
  • Corewell Health William Beaumont University HospitHospital · Royal Oak, MI
  • Henry Ford Health Macomb HospitalHospital · Clinton Township, MI
  • Henry Ford Health Warren HospitalHospital · Warren, MI

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mohammad Hammoude's Medicare patients and services (2024)

790Medicare patients
2,712services billed
73average patient age
66%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes1,088$84.05
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more678$134.68
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes244$139.87
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more228$93.23
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report197$36.48
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more111$178.72
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more80$119.45
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes40$52.63

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Diabetes65%
  • Arthritis53%
  • Ischemic heart disease43%
  • Chronic kidney disease42%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Mohammad Hammoude's Medicare quality score (MIPS 2024)

21.8/100final MIPS score
0quality
0improvement activities
72.7cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as individual. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Mohammad Hammoude (2025)

$3,815.65 in 154 general payments reported in 2025.

TypePaymentsAmount
Food and beverage151$3,761.24
Education3$54.41

Paying companies: Amgen Inc. ($750.02), Novo Nordisk Inc ($521.90), Corcept Therapeutics ($362.87), Abbott Laboratories ($334.96), MannKind Corporation ($245.07), Ascendis Pharma Endocrinology Inc ($197.32).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mohammad Hammoude

What kind of clinician is Dr. Mohammad Hammoude?

Dr. Mohammad Hammoude is listed as a physician specializing in endocrinology, also practicing internal medicine.

Where does Dr. Mohammad Hammoude practice?

Endocrine Shores PC at 44700 Delco Blvd, Suite A, Sterling Heights, MI 48313, and 1 other address in the records.

What is the office phone number for Dr. Mohammad Hammoude?

The listed office number is (586) 446-9600. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Mohammad Hammoude?

The National Provider Identifier is 1265559488.

Does Dr. Mohammad Hammoude accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mohammad Hammoude affiliated with?

Corewell Health Beaumont Grosse Pointe Hospital, Corewell Health Beaumont Troy Hospital, Corewell Health William Beaumont University Hospit, Henry Ford Health Macomb Hospital, Henry Ford Health Warren Hospital.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2009-08-13
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare